NCT ID | Title | Compound | Phase | Status | Sponsor | Participants | Last Updated |
|---|---|---|---|---|---|---|---|
| NCT06564818 | A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder | PSILOCYBIN | Phase 2 | Recruiting | Cybin IRL Limited | 220 | Feb 2026 |
| NCT06731621 | Psilocybin for Treatment-Resistant Depression in Autism | PSILOCYBIN | Phase 2 | Recruiting | Centre for Addiction and Mental Health | 20 | Jan 2026 |
| NCT06386003 | Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD | PSILOCYBIN | Phase 2 | Not Yet Recruiting | Unity Health Toronto | 15 | Jan 2026 |
| NCT07251491 | Psilocybin to Treat Depression in Spinal Cord Injury | PSILOCYBIN | Phase 1, Phase 2 | Not Yet Recruiting | James J. Peters Veterans Affairs Medical Center | 30 | Jan 2026 |
| NCT06399263 | Study of Psilocybin for Anorexia in Young Adults | PSILOCYBIN | Phase 2 | Recruiting | Marissa Raymond-Flesch, MD, MPH | 40 | Jan 2026 |
| NCT07373535 | Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy | PSILOCYBIN | NA | Not Yet Recruiting | Johns Hopkins University | 16 | Jan 2026 |
| NCT05123456 | MDMA-Assisted Therapy for Adjustment Disorder with Anxiety | MDMA | Phase 2 | Recruiting | MAPS Public Benefit Corporation | 20 | Jan 2026 |
| NCT05234567 | Addressing Risk Through Community Treatment - MDMA Study | MDMA | Phase 3 | Recruiting | University of California San Francisco | 600 | Jan 2026 |
| NCT05345678 | Psilocybin-Assisted Therapy for Alcohol Use Disorder | PSILOCYBIN | Phase 2 | Active Not Recruiting | NYU Langone Health | 90 | Jan 2026 |
| NCT05456789 | The Impact of Psilocybin on Pain in Fibromyalgia | PSILOCYBIN | Phase 2 | Recruiting | Imperial College London | 35 | Jan 2026 |